s6y
Company name or ticker
Search
Norwest Venture Partners XIV, LP
4
IMPEL NEUROPHARMA INC: Statement of changes in beneficial ownership of securities
Filed
Thursday, April 29, 2021
Period
Apr 27, 2021
Accession number
0001209191-21-029115
Documents
FORM 4 SUBMISSION
4
On sec.gov
Filing index
All files
Complete submission text
SGML header